Request for Covid-19 Impact Assessment of this Report
The United States Gadoterate Meglumine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Gadoterate Meglumine market, reaching US$ million by the year 2028. As for the Europe Gadoterate Meglumine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Gadoterate Meglumine players cover Guerbet Group, GE, Bayer, and Sanochemia, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Gadoterate Meglumine market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
1.8845Gm/5Ml
3.769Gm/10Ml
5.6535Gm/15Ml
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospitals
Clinics
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Guerbet Group
GE
Bayer
Sanochemia
T2Pharma
b.e.imaging GmbH
Hengrui Medicine
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Gadoterate Meglumine Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Gadoterate Meglumine by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Gadoterate Meglumine by Country/Region, 2017, 2022 & 2028
2.2 Gadoterate Meglumine Segment by Type
2.2.1 1.8845Gm/5Ml
2.2.2 3.769Gm/10Ml
2.2.3 5.6535Gm/15Ml
2.2.4 Others
2.3 Gadoterate Meglumine Sales by Type
2.3.1 Global Gadoterate Meglumine Sales Market Share by Type (2017-2022)
2.3.2 Global Gadoterate Meglumine Revenue and Market Share by Type (2017-2022)
2.3.3 Global Gadoterate Meglumine Sale Price by Type (2017-2022)
2.4 Gadoterate Meglumine Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.5 Gadoterate Meglumine Sales by Application
2.5.1 Global Gadoterate Meglumine Sale Market Share by Application (2017-2022)
2.5.2 Global Gadoterate Meglumine Revenue and Market Share by Application (2017-2022)
2.5.3 Global Gadoterate Meglumine Sale Price by Application (2017-2022)
3 Global Gadoterate Meglumine by Company
3.1 Global Gadoterate Meglumine Breakdown Data by Company
3.1.1 Global Gadoterate Meglumine Annual Sales by Company (2020-2022)
3.1.2 Global Gadoterate Meglumine Sales Market Share by Company (2020-2022)
3.2 Global Gadoterate Meglumine Annual Revenue by Company (2020-2022)
3.2.1 Global Gadoterate Meglumine Revenue by Company (2020-2022)
3.2.2 Global Gadoterate Meglumine Revenue Market Share by Company (2020-2022)
3.3 Global Gadoterate Meglumine Sale Price by Company
3.4 Key Manufacturers Gadoterate Meglumine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Gadoterate Meglumine Product Location Distribution
3.4.2 Players Gadoterate Meglumine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Gadoterate Meglumine by Geographic Region
4.1 World Historic Gadoterate Meglumine Market Size by Geographic Region (2017-2022)
4.1.1 Global Gadoterate Meglumine Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Gadoterate Meglumine Annual Revenue by Geographic Region
4.2 World Historic Gadoterate Meglumine Market Size by Country/Region (2017-2022)
4.2.1 Global Gadoterate Meglumine Annual Sales by Country/Region (2017-2022)
4.2.2 Global Gadoterate Meglumine Annual Revenue by Country/Region
4.3 Americas Gadoterate Meglumine Sales Growth
4.4 APAC Gadoterate Meglumine Sales Growth
4.5 Europe Gadoterate Meglumine Sales Growth
4.6 Middle East & Africa Gadoterate Meglumine Sales Growth
5 Americas
5.1 Americas Gadoterate Meglumine Sales by Country
5.1.1 Americas Gadoterate Meglumine Sales by Country (2017-2022)
5.1.2 Americas Gadoterate Meglumine Revenue by Country (2017-2022)
5.2 Americas Gadoterate Meglumine Sales by Type
5.3 Americas Gadoterate Meglumine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gadoterate Meglumine Sales by Region
6.1.1 APAC Gadoterate Meglumine Sales by Region (2017-2022)
6.1.2 APAC Gadoterate Meglumine Revenue by Region (2017-2022)
6.2 APAC Gadoterate Meglumine Sales by Type
6.3 APAC Gadoterate Meglumine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Gadoterate Meglumine by Country
7.1.1 Europe Gadoterate Meglumine Sales by Country (2017-2022)
7.1.2 Europe Gadoterate Meglumine Revenue by Country (2017-2022)
7.2 Europe Gadoterate Meglumine Sales by Type
7.3 Europe Gadoterate Meglumine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Gadoterate Meglumine by Country
8.1.1 Middle East & Africa Gadoterate Meglumine Sales by Country (2017-2022)
8.1.2 Middle East & Africa Gadoterate Meglumine Revenue by Country (2017-2022)
8.2 Middle East & Africa Gadoterate Meglumine Sales by Type
8.3 Middle East & Africa Gadoterate Meglumine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Gadoterate Meglumine
10.3 Manufacturing Process Analysis of Gadoterate Meglumine
10.4 Industry Chain Structure of Gadoterate Meglumine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Gadoterate Meglumine Distributors
11.3 Gadoterate Meglumine Customer
12 World Forecast Review for Gadoterate Meglumine by Geographic Region
12.1 Global Gadoterate Meglumine Market Size Forecast by Region
12.1.1 Global Gadoterate Meglumine Forecast by Region (2023-2028)
12.1.2 Global Gadoterate Meglumine Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Gadoterate Meglumine Forecast by Type
12.7 Global Gadoterate Meglumine Forecast by Application
13 Key Players Analysis
13.1 Guerbet Group
13.1.1 Guerbet Group Company Information
13.1.2 Guerbet Group Gadoterate Meglumine Product Offered
13.1.3 Guerbet Group Gadoterate Meglumine Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Guerbet Group Main Business Overview
13.1.5 Guerbet Group Latest Developments
13.2 GE
13.2.1 GE Company Information
13.2.2 GE Gadoterate Meglumine Product Offered
13.2.3 GE Gadoterate Meglumine Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 GE Main Business Overview
13.2.5 GE Latest Developments
13.3 Bayer
13.3.1 Bayer Company Information
13.3.2 Bayer Gadoterate Meglumine Product Offered
13.3.3 Bayer Gadoterate Meglumine Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Bayer Main Business Overview
13.3.5 Bayer Latest Developments
13.4 Sanochemia
13.4.1 Sanochemia Company Information
13.4.2 Sanochemia Gadoterate Meglumine Product Offered
13.4.3 Sanochemia Gadoterate Meglumine Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Sanochemia Main Business Overview
13.4.5 Sanochemia Latest Developments
13.5 T2Pharma
13.5.1 T2Pharma Company Information
13.5.2 T2Pharma Gadoterate Meglumine Product Offered
13.5.3 T2Pharma Gadoterate Meglumine Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 T2Pharma Main Business Overview
13.5.5 T2Pharma Latest Developments
13.6 b.e.imaging GmbH
13.6.1 b.e.imaging GmbH Company Information
13.6.2 b.e.imaging GmbH Gadoterate Meglumine Product Offered
13.6.3 b.e.imaging GmbH Gadoterate Meglumine Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 b.e.imaging GmbH Main Business Overview
13.6.5 b.e.imaging GmbH Latest Developments
13.7 Hengrui Medicine
13.7.1 Hengrui Medicine Company Information
13.7.2 Hengrui Medicine Gadoterate Meglumine Product Offered
13.7.3 Hengrui Medicine Gadoterate Meglumine Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Hengrui Medicine Main Business Overview
13.7.5 Hengrui Medicine Latest Developments
14 Research Findings and Conclusion
Table 1. Gadoterate Meglumine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Gadoterate Meglumine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 1.8845Gm/5Ml
Table 4. Major Players of 3.769Gm/10Ml
Table 5. Major Players of 5.6535Gm/15Ml
Table 6. Major Players of Others
Table 7. Global Gadoterate Meglumine Sales by Type (2017-2022) & (K L)
Table 8. Global Gadoterate Meglumine Sales Market Share by Type (2017-2022)
Table 9. Global Gadoterate Meglumine Revenue by Type (2017-2022) & ($ million)
Table 10. Global Gadoterate Meglumine Revenue Market Share by Type (2017-2022)
Table 11. Global Gadoterate Meglumine Sale Price by Type (2017-2022) & (US$/L)
Table 12. Global Gadoterate Meglumine Sales by Application (2017-2022) & (K L)
Table 13. Global Gadoterate Meglumine Sales Market Share by Application (2017-2022)
Table 14. Global Gadoterate Meglumine Revenue by Application (2017-2022)
Table 15. Global Gadoterate Meglumine Revenue Market Share by Application (2017-2022)
Table 16. Global Gadoterate Meglumine Sale Price by Application (2017-2022) & (US$/L)
Table 17. Global Gadoterate Meglumine Sales by Company (2020-2022) & (K L)
Table 18. Global Gadoterate Meglumine Sales Market Share by Company (2020-2022)
Table 19. Global Gadoterate Meglumine Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Gadoterate Meglumine Revenue Market Share by Company (2020-2022)
Table 21. Global Gadoterate Meglumine Sale Price by Company (2020-2022) & (US$/L)
Table 22. Key Manufacturers Gadoterate Meglumine Producing Area Distribution and Sales Area
Table 23. Players Gadoterate Meglumine Products Offered
Table 24. Gadoterate Meglumine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Gadoterate Meglumine Sales by Geographic Region (2017-2022) & (K L)
Table 28. Global Gadoterate Meglumine Sales Market Share Geographic Region (2017-2022)
Table 29. Global Gadoterate Meglumine Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Gadoterate Meglumine Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Gadoterate Meglumine Sales by Country/Region (2017-2022) & (K L)
Table 32. Global Gadoterate Meglumine Sales Market Share by Country/Region (2017-2022)
Table 33. Global Gadoterate Meglumine Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Gadoterate Meglumine Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Gadoterate Meglumine Sales by Country (2017-2022) & (K L)
Table 36. Americas Gadoterate Meglumine Sales Market Share by Country (2017-2022)
Table 37. Americas Gadoterate Meglumine Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Gadoterate Meglumine Revenue Market Share by Country (2017-2022)
Table 39. Americas Gadoterate Meglumine Sales by Type (2017-2022) & (K L)
Table 40. Americas Gadoterate Meglumine Sales Market Share by Type (2017-2022)
Table 41. Americas Gadoterate Meglumine Sales by Application (2017-2022) & (K L)
Table 42. Americas Gadoterate Meglumine Sales Market Share by Application (2017-2022)
Table 43. APAC Gadoterate Meglumine Sales by Region (2017-2022) & (K L)
Table 44. APAC Gadoterate Meglumine Sales Market Share by Region (2017-2022)
Table 45. APAC Gadoterate Meglumine Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Gadoterate Meglumine Revenue Market Share by Region (2017-2022)
Table 47. APAC Gadoterate Meglumine Sales by Type (2017-2022) & (K L)
Table 48. APAC Gadoterate Meglumine Sales Market Share by Type (2017-2022)
Table 49. APAC Gadoterate Meglumine Sales by Application (2017-2022) & (K L)
Table 50. APAC Gadoterate Meglumine Sales Market Share by Application (2017-2022)
Table 51. Europe Gadoterate Meglumine Sales by Country (2017-2022) & (K L)
Table 52. Europe Gadoterate Meglumine Sales Market Share by Country (2017-2022)
Table 53. Europe Gadoterate Meglumine Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Gadoterate Meglumine Revenue Market Share by Country (2017-2022)
Table 55. Europe Gadoterate Meglumine Sales by Type (2017-2022) & (K L)
Table 56. Europe Gadoterate Meglumine Sales Market Share by Type (2017-2022)
Table 57. Europe Gadoterate Meglumine Sales by Application (2017-2022) & (K L)
Table 58. Europe Gadoterate Meglumine Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Gadoterate Meglumine Sales by Country (2017-2022) & (K L)
Table 60. Middle East & Africa Gadoterate Meglumine Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Gadoterate Meglumine Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Gadoterate Meglumine Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Gadoterate Meglumine Sales by Type (2017-2022) & (K L)
Table 64. Middle East & Africa Gadoterate Meglumine Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Gadoterate Meglumine Sales by Application (2017-2022) & (K L)
Table 66. Middle East & Africa Gadoterate Meglumine Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Gadoterate Meglumine
Table 68. Key Market Challenges & Risks of Gadoterate Meglumine
Table 69. Key Industry Trends of Gadoterate Meglumine
Table 70. Gadoterate Meglumine Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Gadoterate Meglumine Distributors List
Table 73. Gadoterate Meglumine Customer List
Table 74. Global Gadoterate Meglumine Sales Forecast by Region (2023-2028) & (K L)
Table 75. Global Gadoterate Meglumine Sales Market Forecast by Region
Table 76. Global Gadoterate Meglumine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Gadoterate Meglumine Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Gadoterate Meglumine Sales Forecast by Country (2023-2028) & (K L)
Table 79. Americas Gadoterate Meglumine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Gadoterate Meglumine Sales Forecast by Region (2023-2028) & (K L)
Table 81. APAC Gadoterate Meglumine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Gadoterate Meglumine Sales Forecast by Country (2023-2028) & (K L)
Table 83. Europe Gadoterate Meglumine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Gadoterate Meglumine Sales Forecast by Country (2023-2028) & (K L)
Table 85. Middle East & Africa Gadoterate Meglumine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Gadoterate Meglumine Sales Forecast by Type (2023-2028) & (K L)
Table 87. Global Gadoterate Meglumine Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Gadoterate Meglumine Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Gadoterate Meglumine Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Gadoterate Meglumine Sales Forecast by Application (2023-2028) & (K L)
Table 91. Global Gadoterate Meglumine Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Gadoterate Meglumine Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Gadoterate Meglumine Revenue Market Share Forecast by Application (2023-2028)
Table 94. Guerbet Group Basic Information, Gadoterate Meglumine Manufacturing Base, Sales Area and Its Competitors
Table 95. Guerbet Group Gadoterate Meglumine Product Offered
Table 96. Guerbet Group Gadoterate Meglumine Sales (K L), Revenue ($ Million), Price (US$/L) and Gross Margin (2020-2022)
Table 97. Guerbet Group Main Business
Table 98. Guerbet Group Latest Developments
Table 99. GE Basic Information, Gadoterate Meglumine Manufacturing Base, Sales Area and Its Competitors
Table 100. GE Gadoterate Meglumine Product Offered
Table 101. GE Gadoterate Meglumine Sales (K L), Revenue ($ Million), Price (US$/L) and Gross Margin (2020-2022)
Table 102. GE Main Business
Table 103. GE Latest Developments
Table 104. Bayer Basic Information, Gadoterate Meglumine Manufacturing Base, Sales Area and Its Competitors
Table 105. Bayer Gadoterate Meglumine Product Offered
Table 106. Bayer Gadoterate Meglumine Sales (K L), Revenue ($ Million), Price (US$/L) and Gross Margin (2020-2022)
Table 107. Bayer Main Business
Table 108. Bayer Latest Developments
Table 109. Sanochemia Basic Information, Gadoterate Meglumine Manufacturing Base, Sales Area and Its Competitors
Table 110. Sanochemia Gadoterate Meglumine Product Offered
Table 111. Sanochemia Gadoterate Meglumine Sales (K L), Revenue ($ Million), Price (US$/L) and Gross Margin (2020-2022)
Table 112. Sanochemia Main Business
Table 113. Sanochemia Latest Developments
Table 114. T2Pharma Basic Information, Gadoterate Meglumine Manufacturing Base, Sales Area and Its Competitors
Table 115. T2Pharma Gadoterate Meglumine Product Offered
Table 116. T2Pharma Gadoterate Meglumine Sales (K L), Revenue ($ Million), Price (US$/L) and Gross Margin (2020-2022)
Table 117. T2Pharma Main Business
Table 118. T2Pharma Latest Developments
Table 119. b.e.imaging GmbH Basic Information, Gadoterate Meglumine Manufacturing Base, Sales Area and Its Competitors
Table 120. b.e.imaging GmbH Gadoterate Meglumine Product Offered
Table 121. b.e.imaging GmbH Gadoterate Meglumine Sales (K L), Revenue ($ Million), Price (US$/L) and Gross Margin (2020-2022)
Table 122. b.e.imaging GmbH Main Business
Table 123. b.e.imaging GmbH Latest Developments
Table 124. Hengrui Medicine Basic Information, Gadoterate Meglumine Manufacturing Base, Sales Area and Its Competitors
Table 125. Hengrui Medicine Gadoterate Meglumine Product Offered
Table 126. Hengrui Medicine Gadoterate Meglumine Sales (K L), Revenue ($ Million), Price (US$/L) and Gross Margin (2020-2022)
Table 127. Hengrui Medicine Main Business
Table 128. Hengrui Medicine Latest Developments
List of Figures
Figure 1. Picture of Gadoterate Meglumine
Figure 2. Gadoterate Meglumine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Gadoterate Meglumine Sales Growth Rate 2017-2028 (K L)
Figure 7. Global Gadoterate Meglumine Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Gadoterate Meglumine Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 1.8845Gm/5Ml
Figure 10. Product Picture of 3.769Gm/10Ml
Figure 11. Product Picture of 5.6535Gm/15Ml
Figure 12. Product Picture of Others
Figure 13. Global Gadoterate Meglumine Sales Market Share by Type in 2021
Figure 14. Global Gadoterate Meglumine Revenue Market Share by Type (2017-2022)
Figure 15. Gadoterate Meglumine Consumed in Hospitals
Figure 16. Global Gadoterate Meglumine Market: Hospitals (2017-2022) & (K L)
Figure 17. Gadoterate Meglumine Consumed in Clinics
Figure 18. Global Gadoterate Meglumine Market: Clinics (2017-2022) & (K L)
Figure 19. Global Gadoterate Meglumine Sales Market Share by Application (2017-2022)
Figure 20. Global Gadoterate Meglumine Revenue Market Share by Application in 2021
Figure 21. Gadoterate Meglumine Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Gadoterate Meglumine Revenue Market Share by Company in 2021
Figure 23. Global Gadoterate Meglumine Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Gadoterate Meglumine Revenue Market Share by Geographic Region in 2021
Figure 25. Global Gadoterate Meglumine Sales Market Share by Region (2017-2022)
Figure 26. Global Gadoterate Meglumine Revenue Market Share by Country/Region in 2021
Figure 27. Americas Gadoterate Meglumine Sales 2017-2022 (K L)
Figure 28. Americas Gadoterate Meglumine Revenue 2017-2022 ($ Millions)
Figure 29. APAC Gadoterate Meglumine Sales 2017-2022 (K L)
Figure 30. APAC Gadoterate Meglumine Revenue 2017-2022 ($ Millions)
Figure 31. Europe Gadoterate Meglumine Sales 2017-2022 (K L)
Figure 32. Europe Gadoterate Meglumine Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Gadoterate Meglumine Sales 2017-2022 (K L)
Figure 34. Middle East & Africa Gadoterate Meglumine Revenue 2017-2022 ($ Millions)
Figure 35. Americas Gadoterate Meglumine Sales Market Share by Country in 2021
Figure 36. Americas Gadoterate Meglumine Revenue Market Share by Country in 2021
Figure 37. United States Gadoterate Meglumine Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Gadoterate Meglumine Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Gadoterate Meglumine Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Gadoterate Meglumine Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Gadoterate Meglumine Sales Market Share by Region in 2021
Figure 42. APAC Gadoterate Meglumine Revenue Market Share by Regions in 2021
Figure 43. China Gadoterate Meglumine Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Gadoterate Meglumine Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Gadoterate Meglumine Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Gadoterate Meglumine Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Gadoterate Meglumine Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Gadoterate Meglumine Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Gadoterate Meglumine Sales Market Share by Country in 2021
Figure 50. Europe Gadoterate Meglumine Revenue Market Share by Country in 2021
Figure 51. Germany Gadoterate Meglumine Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Gadoterate Meglumine Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Gadoterate Meglumine Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Gadoterate Meglumine Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Gadoterate Meglumine Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Gadoterate Meglumine Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Gadoterate Meglumine Revenue Market Share by Country in 2021
Figure 58. Egypt Gadoterate Meglumine Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Gadoterate Meglumine Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Gadoterate Meglumine Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Gadoterate Meglumine Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Gadoterate Meglumine Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Gadoterate Meglumine in 2021
Figure 64. Manufacturing Process Analysis of Gadoterate Meglumine
Figure 65. Industry Chain Structure of Gadoterate Meglumine
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...